Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
April 26, 2022 08:19 ET
|
Biomerica, Inc.
Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial infection H. pylori infection is also a major...
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
April 14, 2022 08:37 ET
|
Biomerica, Inc.
Q3 Net loss per share of $0.01 vs. a net loss of $0.18 per share from same period last year InFoods® IBS diagnostic-guided therapy clinical trial results demonstrated statistically significant...
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome
February 08, 2022 06:39 ET
|
Biomerica, Inc.
InFoods® IBS Diagnostic-Guided Therapy is the first therapy of its kind using science, diet and technology to identify patient specific foods, which when eliminated, help reduce the symptoms of IBS...
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
January 13, 2022 08:19 ET
|
Biomerica, Inc.
Revenues up 239% over prior year fiscal second quarter Customer orders backlog of over $4.0 million at November 30, 2021 Walmart began in-store and online sales of Biomerica’s EZ Detect™ Colon...
Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
December 16, 2021 08:19 ET
|
Biomerica, Inc.
InFoods® IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be Announced in January, 2022. IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc....
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening
November 19, 2021 08:19 ET
|
Biomerica, Inc.
Chaired by Dr. Brooks Cash, Chief of Gastroenterology and Hepatology at the University of Texas Health Center at HoustonScientific Advisory Board to guide on programs to screen and test patients in US...
Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment
November 04, 2021 06:39 ET
|
Biomerica, Inc.
Studies show that 13-20% of Canadians suffer from IBS at any given time1. The lifetime risk for a Canadian to develop IBS is 30%1. IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc....
Biomerica Launches New Website for Its Aware® Breast Exam Device
October 29, 2021 08:19 ET
|
Biomerica, Inc.
Simple at-home breast exam device provides results within minutesStudies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA)...
Walmart to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Screening Test
October 19, 2021 06:39 ET
|
Biomerica, Inc.
Over 4,600 Walmart Stores to sell the EZ Detect™ productSimple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) --...
Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
October 15, 2021 06:39 ET
|
Biomerica, Inc.
Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021 Customer orders backlog of over $1.5 million at August 31, 2021 Following close of first fiscal quarter...